Panacea Biotec is India’s highly progressive research based health management company involved in research, manufacturing and marketing of branded pharmaceutical formulations, vaccines and natural products. The product portfolio includes highly innovative prescription products in important therapeutic areas like pain management, diabetes & cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal care products and vaccines. The flagship brands of the company are Glizid & Glizid-M for Diabetes Management; Panimun Bioral, PanGraf & Mycept for Organ transplantation occupy leadership positions in their respective therapeutic segments. The organisation's focus is to build quality brands that will drive growth of the company. Panacea Biotec is committed towards disease prevention by introducing Innovative Vaccines that helps to reduce child mortality. Our vaccines portfolio consists of Primopol [Oral Polio Vaccine (type I and type III)], Easyfive (DTwP+Hep B+Hib), NovoHib and Polprotec (IPV). Vaccines in the pipeline include Anthrax, Dengue, Japanese encephalitis and several others. Panacea Biotec has earned the distinction of being a WHO pre-qualified for Oral Polio Vaccine and Hepatitis-B vaccine and is in the process of obtaining similar pre-qualifications for other vaccines.